Canada Life’s Standard BioTools LAB Stock Holding History

Canada Life’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20K	Hold	21,480	–	–	﹤0.01%	1826
2025 Q4	$27K	Sell	21,480 -87,123	-80%	-$117K	﹤0.01%	1839
2025 Q3	$137K	Buy	108,603 +87,123	+406%	+$114K	﹤0.01%	1728
2025 Q2	$26K	Hold	21,480	–	–	﹤0.01%	1882
2025 Q1	$23K	Hold	21,480	–	–	﹤0.01%	1921
2024 Q4	$37K	Hold	21,480	–	–	﹤0.01%	1907
2024 Q3	$41K	Hold	21,480	–	–	﹤0.01%	1962
2024 Q2	$38K	Hold	21,480	–	–	﹤0.01%	1990
2024 Q1	$58K	Buy	+21,480	New	+$51.9K	﹤0.01%	2003
2022 Q2	–	Sell	-5,235	Closed	-$20K	–	2448
2022 Q1	$20K	Hold	5,235	–	–	﹤0.01%	2353
2021 Q4	$20K	Hold	5,235	–	–	﹤0.01%	2381
2021 Q3	$35K	Hold	5,235	–	–	﹤0.01%	2323
2021 Q2	$32K	Hold	5,235	–	–	﹤0.01%	2388
2021 Q1	$23K	Hold	5,235	–	–	﹤0.01%	2488
2020 Q4	$31K	Buy	+5,235	New	+$34.4K	﹤0.01%	2445
2020 Q2	–	Sell	-4,303	Closed	-$11K	–	2782
2020 Q1	$11K	Hold	4,303	–	–	﹤0.01%	2494
2019 Q4	$15K	Buy	+4,303	New	+$15.1K	﹤0.01%	2552
2019 Q3	–	Sell	-8,109	Closed	-$100K	–	1732
2019 Q2	$100K	Buy	+8,109	New	+$103K	﹤0.01%	2229
2016 Q4	–	Sell	-1,788	Closed	-$14K	–	2536
2016 Q3	$14K	Hold	1,788	–	–	﹤0.01%	2483
2016 Q2	$16K	Hold	1,788	–	–	﹤0.01%	2485
2016 Q1	$14K	Hold	1,788	–	–	﹤0.01%	2380
2015 Q4	$19K	Hold	1,788	–	–	﹤0.01%	2369
2015 Q3	$15K	Hold	1,788	–	–	﹤0.01%	2356
2015 Q2	$43K	Hold	1,788	–	–	﹤0.01%	2283
2015 Q1	$75K	Hold	1,788	–	–	﹤0.01%	1954
2014 Q4	$60K	Hold	1,788	–	–	﹤0.01%	2024
2014 Q3	$44K	Hold	1,788	–	–	﹤0.01%	2089
2014 Q2	$52K	Buy	+1,788	New	+$57.3K	﹤0.01%	1933

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Canada Life's LAB Position: Q1 2026 in Review

Canada Life held its Standard BioTools (LAB) position steady in Q1 2026 at 21,480 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Canada Life first reported a position in LAB in Q2 2014 and has held it in 28 quarters since. The position peaked at $137K in Q3 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Canada Life held 21,480 shares of Standard BioTools worth $20K as of Q1 2026.
Canada Life left its Standard BioTools share count unchanged in Q1 2026.
Standard BioTools made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1826 holding.
Canada Life first reported a position in Standard BioTools in Q2 2014 and has held it in 28 quarters since.
Canada Life's Standard BioTools position peaked at $137K in Q3 2025.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.